Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release niacin for elevated lipoprotein(a) in hyperlipidemia
ACTRN12611000252910Phase 4Not yet recruiting
- Sponsor
- Kostner
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of niacin in hyperlipidemia, sponsored by Kostner. Primary endpoint: Change in plasma concentrations of high and low molecular weight apo(a) isoforms at 12 weeks. Planned start Apr 2011; status: not yet recruiting.
02
Drugs
niacin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on ACTRN12611000252910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000252910.